Literature DB >> 25449560

Combining cutaneous silent periods with quantitative sudomotor axon reflex testing in the assessment of diabetic small fiber neuropathy.

J T Kamel1, S J Vogrin2, R J Knight-Sadler2, N K Willems2, L Seiderer2, M J Cook2, R J MacIsaac3, L J Roberts2.   

Abstract

OBJECTIVE: Routine electrophysiological testing is often normal in the evaluation of painful diabetic neuropathy, as it is unable to detect dysfunction of thinly myelinated (Aδ) and unmyelinated (C) small fibers. Although cutaneous silent periods (CSP) and quantitative sudomotor axon reflex testing (QSART) respectively evaluate these fiber types in the extremities, these two tests have yet to be assessed together.
METHODS: 26 patients with a clinical diagnosis of small fiber neuropathy (SFN) and 26 age-matched controls were assessed. Nine patients had Type I diabetes, nine had Type II diabetes, and eight had impaired glucose tolerance. The CSP onset latency and duration were recorded in each extremity. QSART was performed on the right side.
RESULTS: 58% (15/26) of patients had abnormal sweat volumes obtained from QSART, while 50% (13/26) of patients had abnormal CSP responses. Combining these two tests increased the sensitivity of testing to 77% (20/26). Abnormalities were seen equally across all patient groups.
CONCLUSIONS: Combining CSP with QSART significantly increases the sensitivity of testing when assessing patients with SFN related to diabetes, or prediabetes. SIGNIFICANCE: For clinically suspected SFN, it is preferable to test more than one small fiber type, as each possess different structural and functional properties and may be heterogeneously affected between patients.
Copyright © 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Neuropathic pain; Small fiber neuropathy

Mesh:

Year:  2014        PMID: 25449560     DOI: 10.1016/j.clinph.2014.09.011

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

Review 1.  Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies.

Authors:  Kelley Newlin Lew; Tracey Arnold; Catherine Cantelmo; Francky Jacque; Hugo Posada-Quintero; Pooja Luthra; Ki H Chon
Journal:  J Diabetes Sci Technol       Date:  2022-01-07

2.  Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists.

Authors:  Brian C Callaghan; Rong Xia; Evan Reynolds; Mousumi Banerjee; Charles Burant; Amy Rothberg; Rodica Pop-Busui; Emily Villegas-Umana; Eva L Feldman
Journal:  Clin Neurophysiol       Date:  2018-01-16       Impact factor: 3.708

3.  The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.

Authors:  Aikaterini Eleftheriadou; Scott Williams; Sarah Nevitt; Emily Brown; Rebecca Roylance; John P H Wilding; Daniel J Cuthbertson; Uazman Alam
Journal:  Diabetologia       Date:  2020-11-09       Impact factor: 10.122

4.  Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping study.

Authors:  Nadine Egenolf; Caren Meyer Zu Altenschildesche; Luisa Kreß; Katja Eggermann; Barbara Namer; Franziska Gross; Alexander Klitsch; Tobias Malzacher; Daniel Kampik; Rayaz A Malik; Ingo Kurth; Claudia Sommer; Nurcan Üçeyler
Journal:  Ther Adv Neurol Disord       Date:  2021-03-23       Impact factor: 6.570

5.  Omega-3 polyunsaturated fatty acid supplementation for improving peripheral nerve health: protocol for a systematic review.

Authors:  Alexis Ceecee Zhang; Richard J MacIsaac; Leslie Roberts; Jordan Kamel; Jennifer P Craig; Lucy Busija; Laura E Downie
Journal:  BMJ Open       Date:  2018-03-25       Impact factor: 2.692

6.  Comparison of Somatic and Sudomotor Nerve Fibers in Type 2 Diabetes Mellitus.

Authors:  Eun Hee Sohn; Kyu Sang Song; Ju Yeon Lee; Ae Young Lee
Journal:  J Clin Neurol       Date:  2017-09-04       Impact factor: 3.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.